CD4 and neoplasm: It has been reported that while CD200 can promote immunosuppression in tumor microenvironment,[47] VTCN1 expression is related to reduced inflammatory CD4 + T-cell response within the microenvironment.[48] Our findings indicate that the expression level of CD200 and VTCN1 may be relevant to a better OS of the low risk patients.